In our dynamic world of life sciences, the journey from innovative idea to market success is complex and challenging. Starting in the early 1940’s the KOL has become an instrumental and pivotal aspect to a viable go to market strategy. One crucial aspect of this...
In the intricate and competitive world of grant applications, the margin for error is often narrow. Review committees, study section chairs, lay-reviewers, and programmatic reviewers all act on the fundamental premise that securing grant funding is not merely about...